Skip to main content

Table 1 Exclusion criteria for participants in the EMA study

From: Design and process of the EMA Cohort Study: the value of antenatal education in childbirth and breastfeeding

Multiple pregnancy
Pathological pregnancy
   · Clinically and/or radiographically documented pelvic abnormality
   · Prior uterine malformation
   · Uterine tumour in current pregnancy
   · Prior uterine surgery
   · Prior genital tract abnormality
   · Positive cytologic testing for malignant cells
   · Prior severe medical or surgical disease (maternal heart disease restricting physical capacity of the woman, neuropathy, coagulopathy, diabetes, etc.)
   · Late cerclage, performed after 16 weeks
   · Active toxoplasmosis during pregnancy
   · German measles during pregnancy
   · Sexually transmitted infection during current pregnancy
   · Gestational diabetes
   · Rh isoimmunisation
   · Foetal malformation
   · Placenta previa
   · Pregnancy-induced HBP
   · Hydramnios of 2 or more litres of amniotic fluid
   · Oligohydramnios lower than 500 mL.
   · Bleeding in the third trimester
   · Suspected or documented IUGR
   · Threatened premature birth
Uncontrolled pregnancy*
Difficult follow-up
   · No telephone, fixed abode, and others
Not speaking Spanish or Basque
  1. Adequate pregnancy control: 6 obstetric visits, some of them in the first trimester of pregnancy. (SEGO, 2002).